2-Furancarboxylicacid,tetrahydro-5-oxo-2-[[(phenylmethoxy)carbonyl]amino]-(9CI)
![]() |
- $350 - $1149
- Product name: 2-Furancarboxylicacid,tetrahydro-5-oxo-2-[[(phenylmethoxy)carbonyl]amino]-(9CI)
- CAS: 104754-51-0
- MF: C13H13NO6
- MW: 279.25
- EINECS:
- MDL Number:MFCD00546276
- Synonyms:2-Furancarboxylicacid,tetrahydro-5-oxo-2-[[(phenylmethoxy)carbonyl]amino]-(9CI);2-Furancarboxylic acid, tetrahydro-5-oxo-2-[[(phenylmethoxy)carbonyl]amino]-
4 prices
Selected condition:
Brand
- AK Scientific
- Alichem
- Crysdot
- TRC
Package
- 500mg
- 5g
- ManufacturerAK Scientific
- Product number7427CJ
- Product description2-(((Benzyloxy)carbonyl)amino)-5-oxotetrahydrofuran-2-carboxylicacid
- Packaging5g
- Price$1149
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number104754510
- Product description2-(((Benzyloxy)carbonyl)amino)-5-oxotetrahydrofuran-2-carboxylicacid
- Packaging5g
- Price$851.72
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD21019357
- Product description2-(((Benzyloxy)carbonyl)amino)-5-oxotetrahydrofuran-2-carboxylicacid 97%
- Packaging5g
- Price$749
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberC228003
- Product description2-(Cbz-amino)-5-oxotetrahydrofuran-2-carboxylicAcid
- Packaging500mg
- Price$350
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 7427CJ | 2-(((Benzyloxy)carbonyl)amino)-5-oxotetrahydrofuran-2-carboxylicacid | 5g | $1149 | 2021-12-16 | Buy |
Alichem | 104754510 | 2-(((Benzyloxy)carbonyl)amino)-5-oxotetrahydrofuran-2-carboxylicacid | 5g | $851.72 | 2021-12-16 | Buy |
Crysdot | CD21019357 | 2-(((Benzyloxy)carbonyl)amino)-5-oxotetrahydrofuran-2-carboxylicacid 97% | 5g | $749 | 2021-12-16 | Buy |
TRC | C228003 | 2-(Cbz-amino)-5-oxotetrahydrofuran-2-carboxylicAcid | 500mg | $350 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|